Table 1.
Group A | Group B | |||||||
---|---|---|---|---|---|---|---|---|
Total | C1 | C2 | C3 | C4 | C5 | C6 | Total | |
Males | 178 (32·90%) | 23 (13·86%) | 47 (27·01%) | 63 (54·78%) | 23 (52·27%) | 10 (52·63%) | 12 (52·17%) | 9 (31.03%) |
Females | 363 (67·10%) | 143 (86·14%) | 127 (72·99%) | 52 (45·22%) | 21 (47·73%) | 9 (47·37%) | 11 (47·83%) | 20 (68·97%) |
Mean age | 57·29 | 46·50 | 55 | 56·18 | 57·56 | 65 | 63·5 | 54·44 |
Median age | 53·72 | 44 | 54·33 | 50 | 54·5 | 62 | 57·5 | 50 |
Age range | 29–81 | 29–58 | 32–72 | 40–68 | 42–73 | 49–76 | 44–81 | 28–84 |
BMI (mean) | 27·86 | 26·58 | 27·09 | 27·65 | 28·17 | 28·23 | 29·5 | 26·92 |
Smoke | 182 (33·64%) | 53 (31·92%) | 58 (33·33%) | 37 (32·17%) | 17 (38·63%) | 8 (42·10%) | 9 (39·13%) | 9 (31·03%) |
Diabetes mellitus | 62 (11·46%) | 16 (9·64%) | 19 (10·91%) | 11 (9·57%) | 7 (15·9%) | 4 (21·05%) | 5 (21·74%) | 3 (10·34%) |
Lipid disorders | 84 (15·52%) | 20 (12·05%) | 24 (13·79%) | 17 (14·78%) | 10 (22·73%) | 6 (31·58%) | 7 (30·44%) | 4 (13·79%) |
Hypertension | 75 (13·86%) | 20 (12·05%) | 17 (9·77%) | 17 (14·78%) | 9 (20·45%) | 5 (26·31%) | 7 (30·44%) | 3 (10·34%) |
Corona phlebectatica | 135 (24·95%) | 14 (8·43%) | 23 (13·22%) | 48 (41·74%) | 23 (52·27%) | 12 (63·15%) | 15 (65·22%) | 0 |
Total | 541 (100%) | 166 (30·68%) | 174 (32·17%) | 115 (21·26%) | 44 (8·13%) | 19 (3·51%) | 23 (4·25%) | 29 (100%) |
C1–C6, clinical stages.